Skip to Content
Merck
CN
  • Differentiation and quantification of synthetic phosphatidylethanol (PEth) homologues by ¹H- and ¹³C-NMR in polar organic solvents.

Differentiation and quantification of synthetic phosphatidylethanol (PEth) homologues by ¹H- and ¹³C-NMR in polar organic solvents.

Analytical and bioanalytical chemistry (2014-05-29)
David Wensbo Posaric, Anders Andersson, Karl-Erik Bergquist, Anders Isaksson
ABSTRACT

Various phosphatidylethanol (PEth) derivatives, the corresponding reversed positional isomers (RPI-PEths), lyso-PEth-16:0, and penta-deuterium-labeled PEth analogs (d5-PEths), were synthesized by enzyme-independent synthetic routes. A general solvent system consisting of a mixture of acetone-d6 and methanol-d4 (97:3; v/v) was found to provide a good solubilizing capacity and excellent hydrogen-1 NMR ((1)H-NMR) peak resolution of various PEth homologues. Analytical differentiation of PEth from the corresponding RPI-PEth by carbon-13 NMR ((13)C-NMR) was demonstrated by comparison of the (13)C-NMR signals of the carbonyl groups, the allylic positions, and of the β-carbons. An exemplary stable long-term room temperature, DMSO-d6-based, and proton-sensitive quantitative nuclear magnetic resonance ((1)H-qNMR) independently quantified calibrator comprising PEth-16:0/18:1 for liquid chromatography (tandem) mass spectrometry (LC-MS/MS) analytical applications were prepared by employment of sodium dodecyl sulfate (SDS) as a solubilizing additive. In summary, novel hypothetically occurring PEth derivatives, e.g., RPI-PEths, have been independently synthesized with regio- and stereochemical control. Use of polar organic solvents, e.g., mixtures of acetone-d6 and methanol-d4 or DMSO-d6, improves spectral line shapes as compared to traditional hydrophobic solvents and allow for analytical differentiation between closely related PEth derivatives, as well as LC-MS/MS-independent concentration determination of dissolved single species by employment of (1)H-qNMR.

MATERIALS
Product Number
Brand
Product Description

Avanti
16:0-18:1 Phosphatidylethanol, Avanti Polar Lipids 840514P, powder
Avanti
16:0-18:1 Phosphatidylethanol, Avanti Polar Lipids 840514C